News

My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs ...
GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and ...
GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...
Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...
Diffusion basis spectrum imaging combined with AI enhances diagnostic accuracy for prostate cancer A study published in the ...
Navigational bronchoscopy was noninferior to CT-guided biopsy when assessing diagnostic accuracy in patients with lung ...
Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique challenges in pain-insensitive individuals.
Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...
Researchers from the UAB have shown that sex hormones accumulate in the skin of sharks. This finding opens a new way for the ...
The global breast biopsy market is anticipated to grow at a steady CAGR of 5.5% during the forecast period 2020-2026, according to a report by Gen Consulting Company.
The father of a six-year-old girl who died following a routine bone marrow biopsy has welcomed steps to make the procedure ...